【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2014 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2014 14
2.2.1 Actavis to Acquire Forest Labs for US$25 Billion 14
2.2.2 Merck Enters into Licensing Agreement with Ablynx for Cancer Immunotherapy 15
2.2.3 Medtronic Completes Public Offering of Notes for US$2 Billion 15
2.2.4 Smith & Nephew Receives Regulatory Approval to Acquire ArthroCare for US$1.7 Billion 15
2.2.5 Mallinckrodt Completes Acquisition of Cadence Pharma for US$1.4 Billion in Tender Offer 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2014 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2014 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2014 21
3.1.1 Top M&A Deals in February 2014 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2013 – February 2014 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2014 25
3.2.1 Top Equity Offering Deals in February 2014 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2013 – February 2014 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2014 28
3.3.1 Top PE/VC Deals in February 2014 29
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2014 30
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2014 31
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2013-February 2014 33
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2013-February 2014 34
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2014 35
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2014 35
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2013 – February 2014 37
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2014 38
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2014 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2013 – February 2014 40
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2013 – February 2014 42
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2013 – February 2014 43
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2013 – February 2014 45
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2014 47
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2014 47
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2014 49
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2014 50
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2014 51
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2014 51
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2013 – February 2014 52
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2013 – February 2014 54
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2013 – February 2014 56
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2013 – February 2014 58
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 60
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2014 60
6.1.1 Oncology – Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2014 63
6.2.1 Central Nervous System – Deals of the Month 64
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2014 66
6.3.1 Infectious Diseases – Deals of the Month 67
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2014 69
6.4.1 Metabolic Disorders – Deal of the Month 70
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2014 72
6.5.1 Immunology – Deal of the Month 73
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2014 75
6.6.1 Cardiovascular – Deal of the Month 76
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, February 2014 77
6.7.1 Gastrointestinal – Deals of the Month 78
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2014 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2014 86
7.2.1 Europe – Deals of the Month 87
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2014 89
7.3.1 Asia-Pacific – Deals of the Month 90
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2014 92
7.4.1 Rest of the World – Deals of the Month 93
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 95
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2013 – February 2014 95
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2013 – February 2014 97
9 Further Information 99
9.1 Methodology 99
9.2 About GlobalData 100
9.3 Disclosure information 101
9.4 Disclaimer 101
【レポート販売概要】
■ タイトル：製薬業界における提携、ライセンシング、投資、M&A動向（2014年2月）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for February 2014 in Pharmaceuticals
■ 発行日：2014年3月31日
■ 調査会社：GlobalData
■ 商品コード：GDPH0450MD
■ 調査対象地域：グローバル
- 糖尿病治療薬の世界市場及びパイプラインインサイト：1型糖尿病、2型糖尿病、糖尿病性足部潰瘍、糖尿病黄斑浮腫、糖尿病性胃アトニー、糖尿病網膜症Diabetes market is a rapidly growing segment with numerous products at different stages of clinical pipeline and others at different phases of industry life cycle. Disease incidences are escalating rapidly across the globe due to which high unmet demand has been created and pharmaceutical companies are trying to provide efficient medical care to patients. Large patient base and superior technology …
- 世界の低侵襲性脊椎圧迫骨折(VCF)装置市場動向（2012-2016）TechNavio's analysts forecast the Global Minimally Invasive VCF Devices market to grow at a CAGR of 10.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of osteoporosis. The Global Minimally Invasive VCF Devices market has also been witnessing an increased focus on reduced risk of cement leakage by vendors. However, the hig …
- C4ISR（指揮・統制・通信・コンピューター・情報・監視・偵察）の世界市場2016-2020About C4ISR As modern combat is conducted at a longer range, the employment of precision technology and a secure communication network ensures mission effectiveness. The systems and services used to ensure seamless communication architecture fall under the domain of C4ISR. The use of C4ISR systems ensures that operators have an advantage when it comes to decision-making, by achieving non-sequentia …
- PAEK（ポリアリールエーテルケトン）の世界市場予測（～2024年）“Increasing demand from oil and gas, electrical and electronics, aerospace, medical and automotive industries to drive the overall growth of PAEK market.”The PAEK market size is expected to grow from USD 851 million in 2019 to USD 1,149 million by 2024, at a CAGR of 6.2% during the forecast period. The PAEK market is driven by various factors, such as high demand from oil and gas, electrical and e …
- 世界の主要なジェネリック医薬品メーカー分析Generic Drug Producers – Discover Top Companies’ Revenue Prospects Now, Benefiting Your Influence What does the future hold for manufacturers and sellers of generic medicines? Visiongain’s new report shows you leading companies’ prospects to 2025. That study lets you discover results, trends, opportunities and revenue forecasts, helping you stay ahead in knowledge. For leading producers and market …
- 機械安全防護ソリューションの世界市場：コンポーネント別（スイッチ、コントローラー、センサー、その他）、用途別（パッケージング、マテリアルハンドリング、鉱業、食品・飲料、医薬品、パッケージング・マテリアルハンドリング、半導体、自動車、工作機械、印刷）、地域別予測Global Machine Safeguarding Solutions Market to reach USD XXX billion by 2025. Global Machine Safeguarding Solutions Market valued approximately USD XXX billion in 2016 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors expected to expand the market are growing government emphasis on safety in industries across the world, a rise …
- 電子楽器の世界市場：製品別、地域別Global Electronic Musical Instruments Market: About this market Technavio’s electronic musical instruments market analysis considers sales from electric pianos and keyboards, string instruments, drums and percussion instruments, and other products. Our study also finds the sales of electronic musical instruments in APAC, Europe, MEA, North America, and South America. In 2019, the electric pianos s …
- アメリカにおけるジェスチャ認識＆タッチレスセンサー市場The touch-less sanitary equipment market covered under the report relates to the products based on the application of capacitive and infrared sensors for faucets, hand dryers, soap dispensers etc. to make it more hygienic and reduce wastage. The gesture recognition technology essentially facilitates the coherence of the human gestures like face, hand or body with the machine in contention to perfo …
- 光干渉断層画像診断法（OTC）の世界市場2017-2021About OCT OCT can help to identify diseases such as diabetic retinopathy and glaucoma at the granular level by providing the images of the retina in layers, which can help physicians identify the disease and form a treatment plan. Technavio’s analysts forecast the global OCT market to grow at a CAGR of 8.16% during the period 2017-2021. [Covered in this report] The report covers the present scenar …
- ファーマコビジランスおよび医薬品安全性ソフトウェアの世界市場：機能別、導入タイプ別（オンプレミス、オンデマンド・クラウドベース）、エンドユーザー別、地域別予測Global Pharmacovigilance and Drug Safety Software Market to reach USD 265.2 billion by 2025. Global Pharmacovigilance and Drug Safety Software Market valued approximately USD 150.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast Year.The global drug safety software market is divided into two segments on the basis of delivery mode, namely, on pr …
- コンクリート流動化剤の世界市場2017-2021About Concrete SuperplasticizerConcrete superplasticizers are a type of linear polymer chemical additives used in cement and concrete manufacturing as high-range water reducers. These chemicals are used to reduce cement-water ratio in concrete mixture, providing a strong finished product at a lower cost. Technavio’s analysts forecast the global concrete superplasticizer market to grow at a CAGR of …
- 術中放射線療法（IORT）の世界市場予測（～2024年）“The intraoperative radiation therapy market is projected to grow at a CAGR of 7.0% during the forecast period.”The global intraoperative radiation therapy market is projected to reach USD 68 million by 2024 from USD 48 million in 2019, at a CAGR of 7.0%. The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors …
- 低侵襲性外科手術の世界市場：低侵襲性手術装置、低侵襲性腹腔鏡検査デバイス、低侵襲性モニタリング/可視化装置About minimal invasive surgery Minimal invasive surgery is a procedure performed through tiny incisions and advanced equipment, which is intended to reduce the damage to human tissues. This is a complex surgical procedure used for the treatment of conditions such as CVDs and bone, gastrointestinal, and spinal disorders. Benefits of minimal invasive surgery include quick recovery, shorter hospital …
- 世界の細胞治療市場及びパイプラインインサイトResearch in cell therapy is transforming the future of medicine. As the life of a human being begins as a cell, these cells undergo a highly complex set of events and finally those few stem become capable of self-renewal and differentiation and develop into the specialized cells in the body. Cell therapy research also offers significant potential for restructuring the method of medical practice. S …
- 特殊テープの世界市場2019-2023About this market The construction industry is a major end-user of specialty tapes. Therefore, the growth in the global construction market is expected to drive the demand for specialty tapes for construction applications. The global housing market has been witnessing significant growth over the last three years, particularly in developed countries such as the US. The growth in the housing market …
